Skip to main content

Why choose us for your Diagnostic Antibody project?

We brings together technical excellence and tailored support to deliver diagnostic antibodies with guaranteed quality and performance.

Antibody characterization

Reproducible antibody production

Full end-to-end project support

A diagnostic antibody partner focused on robust performance and predictable timelines

Whether you’re developing a diagnostic test in industry or a research assay in academia, you face the same challenges: complex samples, cross-reactivity, lot-to-lot consistency, and final-format performance.

Our custom monoclonal antibody services deliver antibodies with guaranteed quality and performance. They help you achieve reliable results faster and avoid costly re-development during validation.

 

Let’s solve your antibody development challenges

 What derails diagnostic antibody development and how we keep your assay on track 

Get a custom diagnostic antibody strategy that tackles the technical and economic challenges below. You reduce re-development risk and keep validation on track.

Tackling specificity in complex samples

Start with matrix-aware screening to control cross-reactivity and off-target binding.

Ensure performance in complex matrices 

Solving complex targets and epitope constraints

Use the right target presentation and epitope strategy to generate binders that recognize the biologically relevant form.

Advance your challenging-target program 

Accelerating development under market and funding pressure

Move faster with an end-to-end antibody development partner to reduce delays, streamline decision-making, and keep your diagnostic program on track in a highly competitive market.

Speed up development with end-to-end support

Ensuring assay-format readiness

Antibodies are screened and selected in format-relevant conditions to ensure performance in the final workflow.

Optimize antibodies for your assay format 

Maintaining performance after conjugation and immobilization

Design with labeling and surfaces in mind to preserve sensitivity and keep background low after conjugation.

Make your antibodies conjugation-ready 

Controlling late-stage costs with reproducibility and supply continuity

Build a robust monoclonal antibody strategy with quality control and scalability in mind to reduce re-development risk, protect timelines, and secure long-term supply.

De-risk validation and scale with confidence 

De-risk your antibody with real-condition characterization services

 

 

Your antibody is characterized and functionally validated early to de-risk development. Specificity and cross-reactivity are confirmed in relevant complex matrices to keep signals clean in real samples. Targeted characterization speeds candidate comparison before moving to the next stage. Performance is proven in the final assay format to avoid late-stage surprises.

Explore your format-specific workflows

Elisa assay development service
IHC antibody generation service
Custom antibodies for flow cytometry
Custom antibodies for immunofluorescence

Get expert help choosing the right application for your antibody

Case report

Discover our AIxplore® Epitope & Paratope Mapping Service through a case report from one of our clients’ projects.

Case Report: From AI Prediction to Experimental Proof — 85% Signal Reduction with AIxplore® Epitope & Paratope Mapping

See the results here

Reproducible antibody production for long-term supply

With custom recombinant antibody production, programs scale from µg to kg with stable, reproducible quality for confident long-term supply. Batch-to-batch consistency protects data integrity and minimizes re-validation. Format-compatible workflows maintain performance across assays, even for complex targets, while reducing risk to time and budget.

 

Scale with reproducible quality

 

 

Sucess Story

To support EpIeTTX1 pharmacokinetic monitoring, ProteoGenix developed a custom monoclonal antibody capable of specifically detecting the intact therapeutic protein in plasma. With a tailored development strategy and validation under real biological conditions, this project helped TELUM Therapeutics clear a critical development hurdle. 

 

See how we solved a complex pharmacokinetic monitoring challenge

 

 Your end-to-end antibody development project with a single partner

Your project is supported end-to-end to keep every step aligned with the final goal. A dedicated PhD-level expert guides the strategy and execution from kickoff to delivery. Deliverables are IP-free, your antibody can be used without restrictions.

Business people shaking hands in the office. Group of business persons in business meeting. Two entrepreneurs on meeting in board room. Corporate business team on meeting in modern office. Female manager discussing new project with her colleagues. Company owner on a meeting with her employee in her office.

Need a quote or more information? Contact us!

    Cart (0 Items)

    Your cart is currently empty.

    View Products